Hepatitis B: The view from West Africa
The Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study began in 2011 in The Gambia, Sénégal and Nigeria. The study aims to reduce the risk of hepatocellular carcinoma (HCC) in West Africa through the suppression of the Hepatitis B virus (HBV). The biological samples collected allo...
Saved in:
Main Authors: | Mario Lepore (Author), Harr F. Njai (Author), Deborah A. Garside (Author), Yusuke Shimakawa (Author), Mary M.E. Crossey (Author), Ramou Njie (Author), Maud Lemoine (Author) |
---|---|
Format: | Book |
Published: |
Health and Social Sciences Research Institute - South Sudan (HSSRI-SS),
2015-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis
by: Dr. Shevanthi Nayagam, MBBS, et al.
Published: (2016) -
Hepatitis B in Sub-Saharan Africa
by: Jessica Howell, et al.
Published: (2014) -
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study
by: Maud Lemoine, PhD, et al.
Published: (2016) -
Prevalence of hepatitis B, C, and D virus infection in Haiti: A systematic review and meta-analysis
by: Jeanne Perpétue Vincent, et al.
Published: (2023) -
Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis
by: Liem B Luong Nguyen, PhD, et al.
Published: (2024)